Apogee Therapeutics
Develops long-acting antibody therapies for atopic dermatitis, asthma, and other inflammatory diseases.
$135.02
After-hours close+0.06 (+0.04%)
At close$134.97(+0.00%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$1.14 | — | — |
| Aug 2026 | −$1.07 | −$1.14 | −6.5% |
| May 2026 | −$1.12 | −$1.06 | +5.4% |
| Mar 2026 | −$1.05 | −$1.03 | +1.9% |
| Nov 2025 | −$1.12 | −$1.11 | +0.9% |
The latest year is open to everyone — the 14 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Jul 2023 | |||
| Mar 2023 | |||
| Dec 2022 | |||
| Sep 2022 | |||
| Jun 2022 | |||
| Mar 2022 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 9, 2026 | −$1.14 | — | — | $10.0M | — | — |
| Aug 10, 2026 | −$1.07 | −$1.14 | −6.5% | $10.0M | $816.0K | −91.8% |
| May 11, 2026 | −$1.12 | −$1.06 | +5.4% | — | — | — |
| Mar 2, 2026 | −$1.05 | −$1.03 | +1.9% | — | — | — |
| Nov 10, 2025 | −$1.12 | −$1.11 | +0.9% | — | — | — |
The latest year is open to everyone — the 14 quarters behind it read with an account. Sign in | ||||||
| Aug 11, 2025 | ||||||
| May 12, 2025 | ||||||
| Mar 3, 2025 | ||||||
| Nov 12, 2024 | ||||||
| Aug 12, 2024 | ||||||
| May 13, 2024 | ||||||
| Mar 5, 2024 | ||||||
| Nov 13, 2023 | ||||||
| Jul 17, 2023 | ||||||
| Mar 31, 2023 | ||||||
| Dec 31, 2022 | ||||||
| Sep 30, 2022 | ||||||
| Jun 30, 2022 | ||||||
| Mar 31, 2022 | ||||||